Results 21 to 30 of about 299,319 (158)

Can parabens be added to cosmetics without posing a risk to human health? A systematic review of its toxic effects

open access: yesRevista de Ciências Farmacêuticas Básica e Aplicada, 2021
Objective: To summarize evidence regarding the toxic potential of administering parabenscontaining cosmetics in  humans. Methods: The systematic review followed the methodology proposed in Preferred Reporting Items for Systematic Reviews and Meta ...
Daiane de Freitas Resende   +4 more
doaj  

Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series. [PDF]

open access: yes, 2015
Psychiatric adverse drug reactions (ADRs) have been reported with statin use, but the literature regarding statin-associated mood/behavioral changes remains limited.
Cham, Stephanie   +2 more
core   +1 more source

New patents on topical anesthetics. [PDF]

open access: yes, 2014
Anesthesia is defined as a total or partial loss of sensation and it may be general, local or topical, depending on the method of drug administration and area of the body affected.
CALVIERI, Stefano   +6 more
core   +1 more source

Artralgia inducida por levofloxacina: Reporte de un caso

open access: yesInfectio, 2019
Woman who initiated second-line rescue therapy for Helicobacter pylori with levofloxacin one gram every 12 hours, amoxicillin 500 mg every 8 hours and lansoprazole 40 mg every 24 hours.
María Alejandra Montoya-Giraldo
doaj   +1 more source

Safety profile of oxcarbazepine: results from a prescription-event monitoring study [PDF]

open access: yes, 2010
Purpose: To monitor safety of oxcarbazepine, prescribed in primary care in England, using prescription-event monitoring (PEM). Methods: Postmarketing surveillance using observational cohort technique of PEM.
Buggy, Y.   +3 more
core   +1 more source

A comparison between two recommendations to conduct and report systematic reviews on drug’s safety

open access: yesSystematic Reviews, 2019
Background Several recommendations are available to conduct and report a systematic review of adverse drug reactions. This study is aimed at identifying and comparing the methodologies of the two most commonly used recommendations to conduct and report ...
Ana Penedones   +2 more
doaj   +1 more source

Development and pilot study of “Smart Cancer Care”: a platform for managing side effects of chemotherapy

open access: yesBMC Health Services Research, 2023
Background As outpatient chemotherapy treatment increases, cancer patients receiving chemotherapy spend more time at home. In addition, since the types of chemotherapy are gradually expanding, it will be essential to prepare patient self-management ...
Cheolkyung Sin   +4 more
doaj   +1 more source

Disclosure and adverse effects of complementary and alternative medicine used by hospitalized patients in the North East of England [PDF]

open access: yes, 2012
Objectives: This study aimed to investigate the prevalence, disclosure and adverse effects of complementary and alternative medicine (CAM) use in hospitalised patients, and to explore the associations between patients’ perceived side-effects and relevant
Baqir, wasim   +3 more
core   +2 more sources

Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2019
Background/Aims Peripheral eosinophilia during tuberculosis (TB) treatment is common, but has not been fully evaluated. The aim of this study was to determine the prevalence and clinical significance of peripheral blood eosinophilia in patients ...
Tae-Ok Kim   +5 more
doaj   +1 more source

Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Targeted therapy and immunotherapy have markedly improved prognosis of advanced melanoma patients. With expanded use of these drugs, a range of cutaneous adverse events has emerged.
Rita Pimenta   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy